Hanall Biopharma Co.,Ltd (009420.KS) KSC

33,400.00

-500(-1.47%)

Updated at September 09 03:30PM

Currency In KRW

Valuation

Market Cap1.96T
Enterprise Value1.95T
P/E Ratio772.35
PEG Ratio3.37
Price/Sales Ratio11.25
Price/Book Ratio10.83
Enterprise/Revenue11.17
Enterprise/EBITDA37.33

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0.01
Operating Margin0.03

Management Effectiveness

Return On Assets0.01
Return On Equity0.01

Income Statement

Revenue138.94B
Revenue/Share2,893.11
Gross Profit73.31B
EBITDA3.35B
Net Income-1.8B
Diluted EPS-35.59

Balance Sheet

Total Cash13.55B
Total Cash/Share261.18
Total Debt1.61B
Total Debt/Equity0.01
Current Ratio2.66
Book Value Per Share3,070.76

Price History

52-Week Change-12.15
52-Week High52,000
52-Week Low24,000
Moving Average 50 Days28,145
Moving Average 200 Days31,443

Statistics

Average Volume310,388
Shares Outstanding50.78M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor263:250
Last Split DateMay 24, 2006